QIAGEN

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. 

CEO
Thierry L. Bernard
CEOThierry L. Bernard
Employees
5,765
Employees5,765
Headquarters
Venlo, Limburg
HeadquartersVenlo, Limburg
Founded
1996
Founded1996
Employees
5,765
Employees5,765

QGEN Key Statistics

Market cap
9.76B
Market cap9.76B
Price-Earnings ratio
24.39
Price-Earnings ratio24.39
Dividend yield
0.55%
Dividend yield0.55%
Average volume
1.25M
Average volume1.25M
High today
$45.38
High today$45.38
Low today
$44.98
Low today$44.98
Open price
$45.32
Open price$45.32
Volume
71.91K
Volume71.91K
52 Week high
$51.88
52 Week high$51.88
52 Week low
$37.63
52 Week low$37.63

Stock Snapshot

With a market cap of 9.76B, QIAGEN(QGEN) trades at $45.02. The stock has a price-to-earnings ratio of 24.39 and currently yields dividends of 55.3%.

On 2025-12-16, QIAGEN(QGEN) stock moved within a range of $44.98 to $45.38. With shares now at $45.02, the stock is trading +0.1% above its intraday low and -0.8% below the session's peak.

Trading activity shows a volume of 71.91K, compared to an average daily volume of 1.25M.

Over the past 52 weeks, QIAGEN(QGEN) stock has traded between a high of $51.88 and a low of $37.63.

Over the past 52 weeks, QIAGEN(QGEN) stock has traded between a high of $51.88 and a low of $37.63.

QGEN News

TipRanks 17h
QIAGEN N.V. Receives Notification on Voting Rights from AFM

Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...

TipRanks 22h
Qiagen price target raised to EUR 42 from EUR 41 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Qiagen (QGEN) to EUR 42 from EUR 41 and keeps an Equal Weight rating on the shares. Claim 50% Off TipRanks Pre...

TipRanks 5d
Qiagen downgraded to Neutral from Buy at Citi

Citi analyst Patrick Donnelly downgraded Qiagen (QGEN) to Neutral from Buy with a price target of $50, down from $55. The firm adjusted ratings in the life scie...

Analyst ratings

63%

of 24 ratings
Buy
37.5%
Hold
62.5%
Sell
0%

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.